Literature DB >> 426159

The Ottawa County project: a report of a tuberculosis screening project in a small mining community.

R M Burke, L P Schwartz, D E Snider.   

Abstract

Following a retrospective review of tuberculosis cases reported from Ottawa County, Oklahoma, from 1969 through 1973, a selective tuberculosis screening project was implemented. Screening of a "target group" of the population, 519 former miners, greater than or equal to 50 years of age, resulted in the discovery of abnormal chest X-rays in 182; (103 with silicosis, 36 with silicotuberculosis, 12 with inactive tuberculosis, and 31 with other abnormalities). Eighty-five of these persons had positive tuberculin skin tests. Preventive therapy was recommended for 50, and 36 completed the prescribed course of treatment. Eight new bacteriologically confirmed cases of tuberculosis were found and treated. A large number of persons (1,904) residing in the same area who were not part of the target group were also screened for tuberculosis. This group contained a large number of positive tuberculin reactors but very few were candidates for isoniazid preventive therapy. Thirteen persons in this group had abnormal chest X-rays consistent with inactive tuberculosis but 12 had been identified and given preventive therapy before the project began. These data suggest that selective approaches to screening for tuberculosis in a community which are based on an in-depth retrospective review of the tuberculosis case register can be highly successful.

Entities:  

Mesh:

Substances:

Year:  1979        PMID: 426159      PMCID: PMC1619039          DOI: 10.2105/ajph.69.4.340

Source DB:  PubMed          Journal:  Am J Public Health        ISSN: 0090-0036            Impact factor:   9.308


  19 in total

1.  ANTITUBERCULOUS CHEMOPROPHYLAXIS IN SILICOTICS.

Authors:  A MONACO
Journal:  Bull Int Union Tuberc       Date:  1964-09

2.  Pneumoconio-tuberculosis. Results of medical and combined medical-surgical therapy.

Authors:  C GERNEZ-RIEUX; E BALGAIRIES; C VOISIN; P FOURNIER
Journal:  Am Rev Respir Dis       Date:  1960-12

3.  Silicosis in Northern Rhodesia copper miners.

Authors:  R PAUL
Journal:  Arch Environ Health       Date:  1961-02

4.  The results of chemotherapy in silicotuberculosis.

Authors:  C S MORROW
Journal:  Am Rev Respir Dis       Date:  1960-12

5.  Anthracosilicosis. Selected aspects related to the evaluation of disability, cavitation, and the unusual x-ray.

Authors:  R T CATHCART; P A THEODOS; W FRAIMOW
Journal:  Arch Intern Med       Date:  1960-09

6.  Results of treatment of pneumoconiosis complicated by tuberculosis.

Authors:  J H RAMSAY; A PINES
Journal:  Br Med J       Date:  1959-09-05

7.  Some facts on the prevalence of silicosis in the United States.

Authors:  V M TRASKO
Journal:  AMA Arch Ind Health       Date:  1956-10

8.  Tuberculosis in anthracosilicosis.

Authors:  P A THEODOS; B GORDON
Journal:  Am Rev Tuberc       Date:  1952-01

9.  Isoniazid-related hepatitis: a U.S. Public Health Service cooperative surveillance study.

Authors:  D E Kopanoff; D E Snider; G J Caras
Journal:  Am Rev Respir Dis       Date:  1978-06

10.  Rifampim-combined chemotherapy in coal worker's pneumoconio-tuberculosis.

Authors:  P Dubois; A Gyselen; J Prignot
Journal:  Am Rev Respir Dis       Date:  1977-02
View more
  3 in total

1.  Potential health impacts of heavy-metal exposure at the Tar Creek Superfund site, Ottawa County, Oklahoma.

Authors:  John S Neuberger; Stephen C Hu; K David Drake; Rebecca Jim
Journal:  Environ Geochem Health       Date:  2008-02-28       Impact factor: 4.609

2.  An attempt to eradicate silicotuberculosis in Ottawa County, Oklahoma.

Authors:  D E Snider; G Dewberry; H Gretz
Journal:  Am J Public Health       Date:  1982-12       Impact factor: 9.308

3.  The evolution of pulmonary tuberculosis in coal miners in Asturias, northern Spain. An attempt to reduce the rate over a 15-year period, 1971-1985.

Authors:  J A Mosquera; L Rodrigo; F Gonzálvez
Journal:  Eur J Epidemiol       Date:  1994-06       Impact factor: 8.082

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.